Stryker Corporation provides a wide range of medical technologies, focusing on products and services within its MedSurg, Neurotechnology, and Orthopaedics segments. The MedSurg segment includes surgical equipment, navigation systems, endoscopic systems, and patient handling products. The Neurotechnology segment offers neurosurgical devices, neurovascular products, and craniomaxillofacial implants. The Orthopaedics segment specializes in implants for joint replacements and trauma surgeries. Notable products from Stryker include the Mako Robotic-Arm Assisted technology and various advanced endoscopic systems.
Stryker operates in the global medical technology market, serving approximately 75 countries. The company generates revenue by selling its products directly to healthcare facilities and through third-party distributors. In 2024, Stryker's net sales reached $22.6 billion, with the MedSurg and Neurotechnology segment contributing 60% and the Orthopaedics segment contributing 40% of total sales. Stryker's primary customers include hospitals, surgical centers, and other healthcare facilities that require advanced medical technologies.
Stryker's operational structure is divided into two main segments: MedSurg and Neurotechnology, and Orthopaedics. Key factors impacting Stryker's business performance include competition from major players like Medtronic, Johnson & Johnson MedTech, and Zimmer Biomet, as well as its significant investment in research and development to sustain its market position. The company's extensive patent portfolio, consisting of approximately 5,600 U.S. patents and 8,600 international patents, underscores its focus on innovation. Additionally, sales patterns show that orthopaedic surgeries tend to decline in summer, while capital equipment sales often peak in the fourth quarter.